FluoretiQ is a Bristol, UK based diagnostics company on a mission to champion antibiotic stewardship with 2 core technology platforms. NANOPLEX® is a rapid 15-minute ID and enumeration to accurately determine the presence of infection and SCFI™ which determines which antibiotics are likely to be most effective for the patient. These 2 technologies revolutionise the way clinicians can manage infections by promoting evidence-based and effective antibiotic treatments